Literature DB >> 18848880

Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition.

Esther van den Berg1, Raoul P Kloppenborg, Roy P C Kessels, L Jaap Kappelle, Geert Jan Biessels.   

Abstract

Vascular risk factors, such as type 2 diabetes mellitus, hypertension, dyslipidemia and obesity, have been associated with an increased risk of cognitive dysfunction, particularly in the elderly. The aim of this systematic review was to compare these risk factors with regard to the nature and magnitude of the associated cognitive decrements. Cross-sectional and longitudinal studies that assessed cognitive functioning in non-demented persons in relation to diabetes/impaired glucose metabolism (k = 36), hypertension (k = 24), dyslipidemia (k = 7) and obesity (k = 6) and that adjusted or matched for age, gender and education were included. When possible, effect sizes (Cohen's d) were computed per cognitive domain. Diabetes and hypertension were clearly associated with cognitive decrements; the results for obesity and dyslipidemia were less consistent. Effect sizes were moderate (median approximately -0.3) for all risk factors. Decline was found in all cognitive domains, although the effects on cognitive speed, mental flexibility and memory were most consistent. Methodological aspects of included studies and implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848880     DOI: 10.1016/j.bbadis.2008.09.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  115 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  The relationship between cognitive function and non-prescribed therapy use in older adults.

Authors:  Ha T Nguyen; Joseph G Grzywacz; Sara A Quandt; Rebecca H Neiberg; Wei Lang; Kathryn Altizer; Eleanor P Stoller; Ronny A Bell; Thomas A Arcury
Journal:  Aging Ment Health       Date:  2012-02-03       Impact factor: 3.658

Review 3.  Mild cognitive impairment in Parkinson's disease.

Authors:  Saul Martinez-Horta; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2019-04-08       Impact factor: 3.575

4.  Diabetes is associated with lower global cognitive function in schizophrenia.

Authors:  Yoichiro Takayanagi; Nicola G Cascella; Akira Sawa; William W Eaton
Journal:  Schizophr Res       Date:  2012-09-29       Impact factor: 4.939

5.  Autophagy involving age-related cognitive behavior and hippocampus injury is modulated by different caloric intake in mice.

Authors:  Wen Dong; Rong Wang; Li-Na Ma; Bao-Lei Xu; Jing-Shuang Zhang; Zhi-Wei Zhao; Yu-Lan Wang; Xu Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  Systematic review: are overweight and obese individuals impaired on behavioural tasks of executive functioning?

Authors:  Sian Fitzpatrick; Sam Gilbert; Lucy Serpell
Journal:  Neuropsychol Rev       Date:  2013-02-05       Impact factor: 7.444

7.  Increases in total cholesterol and low density lipoprotein associated with decreased cognitive performance in healthy elderly adults.

Authors:  Con Stough; Andrew Pipingas; David Camfield; Karen Nolidin; Karen Savage; Saurenne Deleuil; Andrew Scholey
Journal:  Metab Brain Dis       Date:  2019-01-16       Impact factor: 3.584

Review 8.  Diabetes mellitus and cognitive impairments.

Authors:  Elham Saedi; Mohammad Reza Gheini; Firoozeh Faiz; Mohammad Ali Arami
Journal:  World J Diabetes       Date:  2016-09-15

9.  Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors.

Authors:  C Messier; M Gagnon
Journal:  Diabetologia       Date:  2009-09-25       Impact factor: 10.122

10.  Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.

Authors:  Gregory A Moy; Ewan C McNay
Journal:  Physiol Behav       Date:  2012-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.